BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 6391535)

  • 21. The Role of FDG-PET in the Diagnosis and Staging of Ocular Adnexal Lymphoproliferative Disease.
    English JF; Sullivan TJ
    Orbit; 2015; 34(5):284-91. PubMed ID: 26308502
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ocular adnexal lymphoid proliferations: clinical, histologic, flow cytometric, and molecular analysis of forty-three cases.
    Sharara N; Holden JT; Wojno TH; Feinberg AS; Grossniklaus HE
    Ophthalmology; 2003 Jun; 110(6):1245-54. PubMed ID: 12799255
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Benign and malignant orbital lymphoproliferative disorders: Differentiating using multiparametric MRI at 3.0T.
    Xu XQ; Hu H; Liu H; Wu JF; Cao P; Shi HB; Wu FY
    J Magn Reson Imaging; 2017 Jan; 45(1):167-176. PubMed ID: 27299917
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Orbital benign and malignant lymphoproliferative disorders: Differentiation using semi-quantitative and quantitative analysis of dynamic contrast-enhanced magnetic resonance imaging.
    Hu H; Xu XQ; Liu H; Hong XN; Shi HB; Wu FY
    Eur J Radiol; 2017 Mar; 88():88-94. PubMed ID: 28189215
    [TBL] [Abstract][Full Text] [Related]  

  • 25. B- and T-cell markers in lymphoproliferative disorders with blood and bone marrow involvement.
    Katz J; Lea R; Livni N; Lewis D; Lynch SR; Skikne B; Bezwoda W
    S Afr Med J; 1978 May; 53(20):789-92. PubMed ID: 358421
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MRI patterns in orbital malignant lymphoma and atypical lymphocytic infiltrates.
    Akansel G; Hendrix L; Erickson BA; Demirci A; Papke A; Arslan A; Ciftci E
    Eur J Radiol; 2005 Feb; 53(2):175-81. PubMed ID: 15664279
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The immunophenotypic lymphocyte analysis of orbital lymphadenosis and its significance].
    Yu YH; Li J; Zhang PW
    Zhonghua Yan Ke Za Zhi; 1994 May; 30(3):210-3. PubMed ID: 7843004
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of benign orbital pseudolymphomas with the monoclonal anti-CD20 antibody rituximab.
    Witzig TE; Inwards DJ; Habermann TM; Dogan A; Kurtin PJ; Gross JB; Ananthamurthy A; Ristow KM; Garity JA
    Mayo Clin Proc; 2007 Jun; 82(6):692-9. PubMed ID: 17550749
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Lymphoproliferative diseases of the orbit and appendages of the eye].
    Nechesniuk SIu; Probatova NA; Grishina EE; Kovrigina AM; Tupitsyn NN; Sholokhova EN
    Arkh Patol; 2001; 63(1):27-32. PubMed ID: 11242851
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of computed tomographic and cytopathological findings in the evaluation of adult orbital mass.
    Islam MN; Amin MS; Dipi RM; Khan NA
    Mymensingh Med J; 2013 Jan; 22(1):75-9. PubMed ID: 23416813
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Viruses, Immunity and Unusual Lymphoproliferative Disorders of the Chest: Integrating Imaging With Pathogenesis and Clinical Presentations.
    Law A; Shmukler A; Burns J; Haramati LB
    J Comput Assist Tomogr; 2016; 40(1):71-9. PubMed ID: 26484956
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Distribution of lymphocytes with interleukin-2 receptors (TAC antigens) in reactive lymphoproliferative processes, Hodgkin's disease, and non-Hodgkin's lymphomas. An immunohistologic study of 300 cases.
    Sheibani K; Winberg CD; van de Velde S; Blayney DW; Rappaport H
    Am J Pathol; 1987 Apr; 127(1):27-37. PubMed ID: 3105322
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Orbital and adnexal Rosai-Dorfman disease.
    Prabhakaran VC; Bhatnagar A; Sandilla J; Olver J; Leibovitch I; Ghabrial R; Goldberg RA; Selva D
    Orbit; 2008; 27(5):356-62. PubMed ID: 18836933
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lacrimal sac lymphoproliferative lesion: case report.
    Coloma-González I; Ruíz-García L; Ceriotto A; Corredor-Casas S; Salcedo-Casillas G
    Arch Soc Esp Oftalmol; 2015 Mar; 90(3):144-7. PubMed ID: 25443184
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Primary localized orbital amyloidosis.
    Levine MR; Buckman G
    Ann Ophthalmol; 1986 May; 18(5):165-7. PubMed ID: 3717836
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Orbital manifestations of plasmacytic lymphoproliferations.
    de Smet MD; Rootman J
    Ophthalmology; 1987 Aug; 94(8):995-1003. PubMed ID: 3658377
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lymphoid hyperplasia of the orbit and ocular adnexa: A clinical ​pathologic review.
    Andrew NH; Coupland SE; Pirbhai A; Selva D
    Surv Ophthalmol; 2016; 61(6):778-790. PubMed ID: 27127077
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genome-Wide Analysis of Ocular Adnexal Lymphoproliferative Disorders Using High-Resolution Single Nucleotide Polymorphism Array.
    Takahashi H; Usui Y; Ueda S; Yamakawa N; Sato-Otsubo A; Sato Y; Ogawa S; Goto H
    Invest Ophthalmol Vis Sci; 2015 Jun; 56(6):4156-65. PubMed ID: 26120819
    [TBL] [Abstract][Full Text] [Related]  

  • 39. IgG4-related disease in the head and neck.
    Ferry JA; Deshpande V
    Semin Diagn Pathol; 2012 Nov; 29(4):235-44. PubMed ID: 23068303
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pseudo-tumours, a clinical concept.
    Peeters HJ; van Heerde P; Feltkamp-Vroom TM
    Doc Ophthalmol; 1982 Jan; 52(3-4):387-91. PubMed ID: 6896027
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.